AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Trial of Trans-examic Acid in Upper GI Bleeding with Cirrhosis
This chapter focuses on a new trial involving trans-examic acid (TXA) in patients with advanced cirrhosis and hyperfibronolysis, aimed at stabilizing clots in upper gastrointestinal bleeding. Discussions include enrollment criteria for patients with cirrhosis, management strategies like endoscopic therapy, outcomes related to treatment failure and re-bleeding, safety events, and conflicting trial results impacting the administration of TXA in clinical practice.